Moderna, Inc.
MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Asian employees in U.S. workforce by Year
Asian employees in U.S. workforce (%) (%)
Moderna Asian employees in U.S. workforce: 28.0% in FY2025, up 1.0 pts from a year earlier.
Latest, FY2025
28.0%
Period ended Dec 31, 2025
Change on a year earlier
+1.0 pts
27.0% in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
“Women in workforce Turnover (2) Asian 27% 27% 28%”
Source: 2025 Impacting Human Health Report ↗
Reported in Moderna Corporate Responsibility / Impacting Human Health Reports.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Asian employees in U.S. workforce (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28.0% | +1.0 pts | 2025 Impacting Human Health Report ↗ |
| FY2024 | Dec 31, 2024 | 27.0% | 0.0 pts | 2025 Impacting Human Health Report ↗ |
| FY2023 | Dec 31, 2023 | 27.0% | +1.0 pts | 2025 Impacting Human Health Report ↗ |
| FY2022 | Dec 31, 2022 | 26.0% | +2.0 pts | 2024 Impacting Human Health Report ↗ |
| FY2021 | Dec 31, 2021 | 24.0% | – | 2023 ESG Report ↗ |
Cite this data
StockData. (2026). Moderna Asian employees in U.S. workforce (%), annual FY2021–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/hc-us-asian-pct
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.